Tokyo, Japan

Torii Pharmaceutical Co., Ltd.

Calculating rank
USPTO Granted Patents = 4


Forward Citations = 14

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Hiroyuki Uchiyama (2 out of 2 patents)

silverMedal Yoshihiro Watanabe (1 out of 69 patents)

bronzeMedal Keisuke Suzuki (1 out of 79 patents)

4.  Takayuki Mimura (1 out of 3 patents)

5.  Kiyohiko Dohi (1 out of 1 patent)

6.  Takashi Urushihara (1 out of 1 patent)

7.  Masanori Iwata (1 out of 4 patents)

8.  Masahiro Iwaki (1 out of 2 patents)

9.  Hiroyuki Kawamura (1 out of 8 patents)

10.  Toyoo Nakayama (1 out of 13 patents)

11.  Yoshio Tahara (1 out of 1 patent)

12.  Saori Ohmae (1 out of 1 patent)

13.  Naoki Ando (11 patents)

14.  Yoshihiro Watanabe (71 patents)

15.  Masahiro Yamashita (1 patent)


4 patents:

Company Overview
Torii Pharmaceutical Co., Ltd. is a Japan-based pharmaceutical company that specializes in developing, manufacturing, and marketing pharmaceutical products. They focus on a wide range of therapeutic areas including cardiovascular, respiratory, gastrointestinal, and central nervous system disorders. With a commitment to improving the health and well-being of people worldwide, Torii Pharmaceutical Co., Ltd. strives to provide high-quality and innovative pharmaceutical solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#3,058 in Tokyo

#7,590 in Japan

Tokyo, JP
Tokyo, Japan
Forward Citations = 14

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Torii Pharmaceutical Co., Ltd.. Retrieved from https://idiyas.com/company/torii-pharmaceutical-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…